The BRECISE Consortium will hold its next Plenary Meeting as a face-to-face event in London, on 12–13 March 2026.

The meeting will be organised in the vicinity of ExCeL London, aligning with the timing of the EAU Congress 2026. Holding the plenary in parallel with this major international scientific event will support alignment between BRECISE activities and ongoing developments in urology, oncology, and biomarker-driven innovation.

The plenary meeting will provide a structured forum for consortium partners to review progress across work packages, discuss interim scientific and technical results, and coordinate next steps for the implementation and dissemination of project outcomes. Dedicated sessions will also allow for cross-partner exchange on regulatory, clinical, and data-related aspects relevant to the BRECISE framework.

The meeting will run from 12:00 on 12 March to 14:00 on 13 March 2026, allowing participants to combine attendance at the BRECISE plenary with participation in the EAU Congress, where relevant.

The agenda will be published soon. 

Stay updated and follow us for more updates on LinkedIn: https://www.linkedin.com/company/brecise/.